Microglia in cancer: For good or for bad?

17Citations
Citations of this article
46Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Glioblastoma is a malignant tumor of astrocytic origin that is highly invasive, proliferative and angiogenic. Despite current advances in multimodal therapies, such as surgery, radio- and chemotherapy, the outcome for patients with glioblastoma is nearly always fatal. The glioblastoma microenvironment has a tremendous influence over the tumor growth and spread. Microglia and macrophages are abundant cells in the tumor mass. Increasing evidence indicates that glioblastoma recruits these cell populations and signals in a way that microglia and macrophages are subverted to promote tumor progression. In this chapter, we discuss some aspects of the interaction between microglia and glioblastoma, consequences of this interaction for tumor progression and the possibility of microglial cells being used as therapeutic vectors, which opens up new alternatives for the development of GBM therapies targeting microglia.

Cite

CITATION STYLE

APA

Da Fonseca, A. C. C., Amaral, R., Garcia, C., Geraldo, L. H., Matias, D., & Lima, F. R. S. (2016). Microglia in cancer: For good or for bad? Advances in Experimental Medicine and Biology, 949, 245–261. https://doi.org/10.1007/978-3-319-40764-7_12

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free